Hong Kong Pharma Digital Technology Holdings Limited (HKPD)

HKPD Income Statement

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023
Revenue	20.77	16.69	12.56
Revenue Growth (YoY)	-	32.91%	-
Cost of Revenue	16.64	13.13	9.82
Gross Profit	4.13	3.56	2.74
Selling, General & Admin	1.78	1.89	1.76
Other Operating Expenses	-0	0	0
Operating Expenses	1.77	1.89	1.76
Operating Income	2.35	1.67	0.98
Interest Expense	-0.1	-0.08	-0.02
Interest & Investment Income	0	0	0
Currency Exchange Gain (Loss)	-0.03	-0.06	-0.03
EBT Excluding Unusual Items	2.23	1.52	0.92
Gain (Loss) on Sale of Assets	-0	0	-
Other Unusual Items	0	0	0.1
Pretax Income	2.23	1.53	1.02
Income Tax Expense	0.32	0.2	0.02
Net Income	1.91	1.33	1
Net Income to Common	1.91	1.33	1
Net Income Growth	-	33.21%	-
Shares Outstanding (Basic)	9	7	7
Shares Outstanding (Diluted)	9	7	7
Shares Change (YoY)	-	7.64%	-
EPS (Basic)	0.21	0.18	0.15
EPS (Diluted)	0.21	0.18	0.15
EPS Growth	-	23.40%	-
Free Cash Flow	0.4	-0.45	1.61
Free Cash Flow Per Share	0.04	-0.06	0.24
Gross Margin	19.88%	21.32%	21.81%
Operating Margin	11.34%	10.00%	7.80%
Profit Margin	9.19%	7.97%	7.95%
Free Cash Flow Margin	1.93%	-2.68%	12.84%
EBITDA	2.42	1.73	1.05
EBITDA Margin	11.66%	10.38%	8.39%
D&A For EBITDA	0.07	0.06	0.07
EBIT	2.35	1.67	0.98
EBIT Margin	11.34%	10.00%	7.80%
Effective Tax Rate	14.41%	12.86%	2.21%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q